These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19204831)

  • 1. Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model.
    Li W; Liu H; Yang X; Zheng J; Wang Y; Si L
    Acta Biochim Biophys Sin (Shanghai); 2009 Feb; 41(2):137-45. PubMed ID: 19204831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction of prophylactic recombinant HPV58-attenuated Shigella vector live vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model].
    Li WS; Liu HL; Zhang YT; Yang XF; Wang YL; Si LS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1163-6. PubMed ID: 18062891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model.
    Yan X; Wang D; Liang F; Fu L; Guo C
    Hum Vaccin Immunother; 2014; 10(12):3491-8. PubMed ID: 25483698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of HPV L1 into Shigella surface IcsA: a new approach in developing live attenuated Shigella-HPV vaccine.
    Xu D; Wang D; Yang X; Cao M; Yu J; Wang Y
    Antiviral Res; 2014 Feb; 102():61-9. PubMed ID: 24333518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.
    Hartman AB; Van de Verg LL; Collins HH; Tang DB; Bendiuk NO; Taylor DN; Powell CJ
    Infect Immun; 1994 Feb; 62(2):412-20. PubMed ID: 7507892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
    Yang XF; Zhou L; Zheng J; Si LS; Wang YL
    Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model.
    Hartman AB; Venkatesan MM
    Infect Immun; 1998 Sep; 66(9):4572-6. PubMed ID: 9712824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a new recombinant IpaC from Shigella dysenteriae type I in guinea pig as a vaccine candidate.
    Malaei F; Hesaraki M; Saadati M; Ahdi AM; Sadraeian M; Honari H; Nazarian S
    Iran J Immunol; 2013 Jun; 10(2):110-7. PubMed ID: 23811550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of prophylactic human papillomavirus type 16 L1 capsid protein vaccine delivered by live attenuated Shigella flexneri strain sh42.
    Yang XF; Qu XZ; Wang K; Zheng J; Si LS; Dong XP; Wang YL
    Acta Biochim Biophys Sin (Shanghai); 2005 Nov; 37(11):743-50. PubMed ID: 16270153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of
    Turbyfill KR; Clarkson KA; Vortherms AR; Oaks EV; Kaminski RW
    mSphere; 2018; 3(2):. PubMed ID: 29600284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carboxyl terminus truncated HPV58 virus L1 protein expressed with baculovirus system and its bioactivity].
    Li WS; Zheng J; Liu HL; Chen HW; Yang J; Wang YL; Si LS
    Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):536-9. PubMed ID: 15968984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.
    Venkatesan MM; Hartman AB; Newland JW; Ivanova VS; Hale TL; McDonough M; Butterton J
    Infect Immun; 2002 Jun; 70(6):2950-8. PubMed ID: 12010984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates.
    Ranallo RT; Fonseka S; Boren TL; Bedford LA; Kaminski RW; Thakkar S; Venkatesan MM
    Vaccine; 2012 Jul; 30(34):5159-71. PubMed ID: 22658966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
    Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buprenorphine on immunogenicity and protective efficacy in the guinea pig keratoconjunctivitis model (Sereny test).
    Hanson CE; Ruble GR; Essiet I; Hartman AB
    Comp Med; 2001 Jun; 51(3):224-9. PubMed ID: 11924776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a.
    Liu Q; Su H; Bian X; Wang S; Kong Q
    Int J Med Microbiol; 2020 Jul; 310(5):151427. PubMed ID: 32654768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
    Wang H; Yu JY; Li L
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
    Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.
    Shim DH; Suzuki T; Chang SY; Park SM; Sansonetti PJ; Sasakawa C; Kweon MN
    J Immunol; 2007 Feb; 178(4):2476-82. PubMed ID: 17277155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.